OakChart

Ardent Health Inc

ARDTHealthcare·Medical Care Facilities·USA·Mid·NYSE·Nov 11 • 9:13 AM ET

17.60-0.33 (-1.84%)
2026-11-11 15:19 CET
Market cap
2,526.98 USD m
Revenue, TTM
6,454.05 USD m
Net income, TTM
146.22 USD m
Free cash flow, TTM
282.30 USD m
EPS diluted, TTM
1.03
P/E
17.09
Compare

Price

ARDT against its 20, 50 and 200-day averages
2050200beatmiss
7.5010.0012.5015.0017.501.7M3.5MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ARDTclose 17.6020-day 13.4050-day 11.86200-day 10.2617.60

5.2% under 18.57 on 9 Nov 2026. Last 15 sessions, 60.8% high to low

Profile

ARDT
52-week range, 91% of the way up
7.7118.57

Ardent Health, Inc. engages in the provision of healthcare and related services. It also owns and operates hospitals through its subsidiaries. The company was founded in 1993 and is headquartered in Brentwood, TN.

IndexRUT
Employees25200
IPOJul 18, 2024
Beta0.27
ATR, 14d0.80
Rel volume0.00
Short float15.69%
Insider own84.41%
Inst own15.88%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.48B
Enterprise Value4.36B
Income146.22M
Sales6.45B
Book/sh9.91
Cash/sh5.44
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees25200
IPOJul 18, 2024

Ratios

P/E17.09
Forward P/E14.22
PEG1.33
P/S0.38
P/B1.78
P/C3.24
P/FCF8.79
EV/EBITDA8.67
EV/Sales0.68
Quick Ratio2.03
Current Ratio2.13
Debt/Eq1.62
LT Debt/Eq1.60
Option/ShortYes / Yes

Earnings

EPS (ttm)1.03
EPS next Y1.24
EPS next Q0.35
EPS this Y9.02%
EPS next Y18.28%
EPS next 5Y10.67%
EPS past 3/5Y-10.04% -
Sales past 3/5Y7.23% 8.73%
EPS Y/Y TTM-28.50%
Sales Y/Y TTM2.03%
EPS Q/Q289.05%
Sales Q/Q3.05%
EarningsNov 04 AMC
EPS/Sales Surpr.33.62% 1.31%

Ownership

Insider Own84.41%
Insider Trans0.02%
Inst Own15.88%
Inst Trans0.92%
ROA2.78%
ROE11.10%
ROIC4.03%
Gross Margin15.40%
Oper. Margin5.22%
Profit Margin2.27%
SMA2031.32%
SMA5048.44%
SMA20071.59%
Trades-

Technical

Shs Outstand140.93M
Shs Float21.97M
Short Float15.69%
Short Ratio6.54
Short Interest3.45M
52W High18.57 -5.22%
52W Low7.71 128.27%
Volatility9.62% 5.08%
ATR (14)0.80
RSI (14)81.98
Beta0.27
Rel Volume0.00
Avg Volume526.70K
Volume129

Performance

Perf Week35.49%
Perf Month50.56%
Perf Quarter59.71%
Perf Half Y77.60%
Perf YTD99.32%
Perf Year25.27%
Perf 3Y-
Perf 5Y-
Perf 10Y-
Recom2.00
Target Price16.46
Prev Close17.93
Price17.60
Change %-1.84%

Analyst ratings

latest 10 of 19
DateActionAnalystRating changeTargetImplied
Sep 23, 2026InitiatedBBMO Capital MarketsMarket Perform$11-37.5%
Nov 17, 2025DowngradeKKeyBanc Capital MarketsOverweight → Sector Weight
Nov 14, 2025DowngradeMMorgan StanleyOverweight → Equal-Weight
Oct 14, 2025InitiatedGGoldmanNeutral$19+8.0%
Sep 10, 2025InitiatedUUBSBuy$17-3.4%
Jul 16, 2025DowngradeBBofA SecuritiesNeutral → Underperform$14.60-17.0%
Dec 17, 2024ResumedJJP MorganNeutral$20+13.6%
Nov 06, 2024DowngradeBBofA SecuritiesBuy → Neutral$22 → $19+8.0%
Oct 11, 2024InitiatedKKeyBanc Capital MarketsOverweight$24+36.4%
Aug 12, 2024InitiatedTTruistBuy$21+19.3%

Peers

Mkt cap
TickerCompanyMkt cap
CYHCommunity Health Systems Inc306.03M
UHSUniversal Health Services Inc11.08B
THCTenet Healthcare Corp22.84B
HCAHCA Healthcare Inc104.66B
NUTXNutex Health Inc1.28B
SGRYSurgery Partners Inc3.47B
ACHCAcadia Healthcare Company Inc3.59B
AUNAAuna SA340.46M
EHCEncompass Health Corp13.95B
MDPediatrix Medical Group Inc2.41B

Insider trading

6 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Bonick MartinFormer Officer & DirectorAug 27 '26Proposed Sale11.0835,930398,031Aug 27 04:18 PM
Bonick MartinFormer Officer & DirectorAug 25 '26Proposed Sale11.1735,930401,355Aug 25 04:47 PM
Bonick MartinFormer Officer & DirectorAug 20 '26Proposed Sale10.5035,930377,364Aug 20 04:23 PM
Bonick MartinFormer Officer & DirectorAug 18 '26Proposed Sale10.9535,930393,482Aug 18 04:11 PM
DeMichiei RobertDirectorJun 05 '26Buy8.7311,26098,30035,564Jun 08 12:50 PM
LUMSDAINE ALFREDChief Financial OfficerJun 05 '26Buy8.8110,00088,100329,183Jun 08 12:50 PM

Held by

AUM
TickerCompanyAUM
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
IWMiShares Russell 2000 Index FundAUM: 77.38B
BSVOEA Bridgeway Omni Small-Cap Value ETFAUM: 2.44B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
FYXFirst Trust Small Cap Core AlphaDEX FundAUM: 1.39B
DFSVUS Small Cap Value Portfolio ETF Class Shares-
IWNiShares Russell 2000 Value ETFAUM: 14.10B
EESWisdomTree U.S. SmallCap FundAUM: 684.87M
VXFVanguard Extended Market Index ETFAUM: 30.47B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B

News

latest 14 of 206
  • Ardent Health to Participate in the UBS Global Healthcare Conference (Business Wire)
  • Lovelace parent turns $45 million profit, trims labor costs (Albuquerque Journal, N.M.) +22.40% +8.81%
  • Ardent Health Beats On Cost Discipline And Lifts EBITDA Floor, But Flat Pricing And Soft Surgeries Keep Revenue Pinned Low (Earnings Whispers)
  • Ardent Health Reports Third Quarter 2026 Results (Business Wire) +10.93%
  • Ardent Health's Self-Help Story Faces A Volume Test As New CEO Defends EBITDA Guide (Earnings Whispers)
  • Loading…
  • Ardent Health Appoints Gaurav Khanna as Chief Digital & Information Officer (Business Wire)
  • Ardent Health Announces Third Quarter 2026 Results Conference Call and Webcast Date (Business Wire)
  • The University of Kansas Health System and Ardent Health Announce Plans to Transition Ownership of St. Francis Campus (Business Wire)
  • Ardent Health Hospitals Earn Recognition in U.S. News & World Report's 2026-2027 Best Hospitals Rankings (Business Wire)
  • HealthStream Defines a New Enterprise Category Alongside the EHR and ERP, the Enterprise Clinical Workforce Platform (ECWP) (Business Wire)
  • Ardent Health Marks Expansion of Specialty Care in New UT Tyler School of Medicine (Business Wire)
  • Ardent Health to Participate in the Wells Fargo 21st Annual Healthcare Conference (Business Wire)
  • Oklahoma Heart Institute Brings New National Cardiovascular Trials and Technologies to Patients Across the Region (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-040.3100.2320.3111,6251,60410
2026Q22026-08-040.1200.1820.1181,6221,59011
2026Q12026-05-050.2800.1910.2811,6021,57810
2025Q42026-03-040.3200.3170.3161,6051,63111
2025Q32025-11-12-0.1700.419-0.1661,5771,54911
2025Q22025-08-050.5200.2260.5161,6451,5108
2025Q12025-05-060.2900.2010.2941,4971,4989
2024Q42025-02-260.8100.4760.8001,6061,4848
2024Q32024-11-060.1900.3090.1841,4501,4529
2024Q22024-08-140.3400.3070.3001,4711,4609
2024Q12024-05-290.204-0.1891,439--
2026Q4--0.345--1,63411
2027Q1--0.298--1,6418
2027Q2--0.246--1,6658
2027Q3--0.301--1,6537
2027Q4--0.377--1,6876

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2024FY1.5801.2131.4745,9665,843
2025FY0.9601.0480.9606,3246,356
2026FY-1.020--6,476
2027FY-1.226--6,688
2028FY-1.301--6,961

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0511011,6341,6021,659
2026Q4S2026-11-0411011,6331,6021,659
2026Q4S2026-10-1911011,6331,6021,659
2026Q4S2026-09-2611051,6331,6021,659
2026Q4S2026-09-2311061,6331,6021,659
2026Q4S2026-09-2111071,6331,6021,659
2026Q4S2026-09-0110091,6311,6021,659
2026Q4S2026-08-0610081,6331,6021,676
2026Q4S2026-08-0510091,6331,6021,676
2026Q4S2026-07-2110081,6431,6211,676
2026Q4S2026-07-2010071,6451,6211,676
2026Q4S2026-07-1310081,6451,6211,676
2026Q4S2026-07-1010061,6511,6241,687
2026Q4S2026-07-0810041,6611,6241,697

Estimate history

EPS, annual---1.0771.3190.3761.4740.961.0297
Period20152016201720212022202320242025TTM
EPS, quarterly0.1840.80.2940.516-0.1660.3160.2810.1180.314
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual2029.3722105.2163002.0764870.3965129.6875409.4835966.0726324.3396454.05
Period20152016201720212022202320242025TTM
Sales, quarterly1449.8171606.2891497.2341645.281576.7461605.0791601.871622.2451624.856
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual252.763255.229385.535143.263143.263143.263142.748142.864140.932
Period20152016201720212022202320242025MRQ
Shares, quarterly142.736142.748143.038143.099143.17142.864143.134141.911140.932
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2017FY2016FY
Total Revenue6,454.056,324.345,966.075,409.485,129.694,870.40-3,002.082,105.22
Cost of Goods Sold Incl. D&A5,460.345,351.455,064.094,741.904,465.024,196.86-2,663.141,871.20
Gross Profit993.71972.89901.98667.58664.67673.54-338.94234.01
Other Operating Expense656.93647.31496.22451.80464.46371.16-218.72149.26
Operating Income336.78325.58405.76215.78200.20302.38-120.2284.75
Interest Expense47.8144.4446.5758.1085.64104.56-70.7426.95
Unusual Expense0.00-15.31-1.52-8.46-35.47-86.55--1.5520.49
Net Income Before Taxes291.19286.36363.06151.61311.48295.89-50.6444.37
Income Taxes60.3656.2263.3522.6446.1151.31-49.878.02
Consolidated Net Income230.83230.13299.71128.98265.37244.58-0.7736.35
Net Income From Continuing Operations146.22135.81210.3453.90188.91154.26--35.6514.60
Net Income146.22135.81210.3453.90188.91154.26--35.6514.60
EPS (Recurring)1.030.881.470.331.150.65---
EPS (Basic, Before Extraordinaries)1.040.961.470.381.321.08---
EPS (Diluted)1.030.961.470.381.321.08---
EBITDA503.20481.29552.05356.62338.38439.58-229.75156.27
Non-Operating Income (Expense)2.22-10.102.34-14.53161.4511.52--0.407.05
Other After Tax Adjustments0.000.000.000.000.000.00-0.000.00
Stock Option Compensation Expense27.8531.0413.620.710.480.40---
Price To Earnings Ratio17.4117.4126.5325.83-----
Price To Sales Ratio0.230.200.41------
Gross Margin15.4015.3815.1212.3412.9613.83-11.2911.12
Operating Margin5.225.156.803.993.906.21-4.004.03
Net Margin2.272.153.531.003.683.17--1.190.69
Shares Outstanding140.93142.86142.75143.26143.26143.26-385.54255.23
Market Capitalization2,526.982,526.982,437.882,373.65-----

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue1,624.861,622.241,601.871,605.081,576.751,645.281,497.231,606.29
Cost of Goods Sold Incl. D&A1,366.701,391.631,355.811,346.201,361.571,344.301,299.381,307.35
Gross Profit258.16230.61246.06258.88215.17300.98197.86298.94
Other Operating Expense162.81174.84165.15154.13198.71163.70130.77141.37
Operating Income95.3455.7780.91104.7516.46137.2867.09157.57
Interest Expense15.6111.1510.7410.3010.9911.8411.309.88
Unusual Expense0.000.000.000.007.700.560.22-4.70
Net Income Before Taxes81.0343.2074.5992.37-2.20121.9974.20167.25
Income Taxes17.648.5116.1018.11-3.4126.2915.2326.36
Consolidated Net Income63.3934.6958.4974.261.2195.7058.97140.89
Net Income From Continuing Operations44.5216.9039.8544.96-23.4872.9541.38114.20
Net Income44.5216.9039.8544.96-23.4872.9541.38114.20
EPS (Recurring)0.310.120.280.32-0.130.520.300.78
EPS (Basic, Before Extraordinaries)0.320.120.280.32-0.170.520.300.80
EPS (Diluted)0.310.120.280.32-0.170.520.290.80
EBITDA136.4097.11123.90145.7955.61176.59103.29195.43
Non-Operating Income (Expense)1.29-1.424.42-2.080.03-2.8918.6214.85
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense7.316.287.057.207.648.887.327.19
Price To Earnings Ratio17.4110.398.926.127.398.669.3426.53
Price To Sales Ratio0.230.220.190.200.300.310.320.41
Gross Margin15.8914.2215.3616.1313.6518.2913.2118.61
Operating Margin5.873.445.056.531.048.344.489.81
Net Margin2.741.042.492.80-1.494.432.767.11
Shares Outstanding140.93141.91143.13142.86143.17143.10143.04142.75
Market Capitalization2,526.981,410.561,223.241,264.351,896.151,953.981,962.812,437.88

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2017FY2016FY2015FY
Cash & Short Term Investments709.60556.78437.58456.12--71.9692.61-
Short Term Receivables761.70749.03785.76611.96--453.85261.04-
Inventories118.59115.09105.48107.15--84.1647.09-
Other Current Assets468.93411.84289.27234.01--126.4470.41-
Total Current Assets2,058.821,832.751,618.091,409.25--736.42471.15-
Net Property, Plant & Equipment2,144.022,039.052,012.241,990.15--591.57256.53-
Total Investments and Advances0.003.269.1021.40--0.000.00-
Long-Term Note Receivable61.908.208.708.00-----
Intangible Assets968.79929.01921.63921.63--896.44316.27-
Deferred Tax Assets6.89383.85403.70415.46--87.263.65-
Other Assets49.79131.50129.3193.98--62.8337.76-
Total Assets5,290.215,327.635,102.774,859.88--2,374.521,085.36-
Short Term Debt Incl. Current Port. of LT Debt76.9455.6261.0358.42--16.887.67-
Accounts Payable457.94401.25474.54320.80--226.48131.94-
Income Tax Payable15.0115.2018.0217.35-----
Other Current Liabilities496.66473.36440.51412.03--263.98188.53-
Total Current Liabilities1,046.54945.42994.10808.60--507.35328.14-
Long Term Debt2,241.012,226.572,335.582,329.93--935.81232.70-
Provision for Risks Charges0.000.000.000.00--0.000.00-
Deferred Tax Liabilities-371.53371.21381.03-----
Other Liabilities317.69261.75319.55290.01--171.09128.51-
Total Liabilities3,605.243,805.274,020.453,809.57--1,614.24689.36-
Non-Equity Reserves0.000.000.000.00--0.000.00-
Preferred Stock - Carrying Value0.000.000.000.00--0.000.00-
Common Equity1,287.901,131.38670.90639.05--377.72266.54-
Total Shareholders Equity1,287.901,131.38670.90639.05--377.72266.54-
Accumulated Minority Interest397.07390.98411.42411.26--382.55129.47-
Total Equity1,684.961,522.361,082.321,050.31--760.28396.01-
Total Liabilities & Stockholders Equity5,290.215,327.635,102.774,859.88--2,374.521,085.36-
Book Value Per Share9.017.934.684.46--0.981.04-
Tangible Book Value Per Share2.231.42-1.75-1.97---1.35-0.19-
Full-Time Employees25,20024,900-------
Price to Book Ratio1.812.422.36------
Return on Assets2.564.031.08----2.06--
Return on Equity11.2323.348.23----11.07--
Return on Invested Capital3.856.261.796.36---2.712.92-
Quick Ratio1.851.821.521.61--1.291.29-
Current Ratio1.971.941.631.74--1.451.44-

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2017FY2016FY
Net Income230.83230.13299.71128.98265.37244.58-0.7736.35
Depreciation166.42155.70146.29140.84138.17137.20-109.5371.51
Other Funds (Non Cash)22.7841.8526.744.19-162.3656.90-9.4119.68
Funds from Operations458.94471.28496.78278.01287.30408.03-169.41114.83
Extraordinary Item0.000.000.000.000.000.00-0.000.00
Changes in Working Capital22.94-3.34-181.75-56.31-325.65-261.12--49.94-30.71
Cash from Operating Activities481.88467.94315.03221.70-38.36146.91-119.4784.12
Capital Expenditures-199.57-211.90-187.51-137.41-151.11-139.00--121.53-80.50
Net Assets From Acquisitions-2.50-2.50-35.540.000.00-2.93--899.30-22.85
Sale of Fixed Assets and Businesses0.000.004.300.00206.374.20-41.7519.36
Purchase or Sale of Investments0.000.000.000.000.000.00-0.000.00
Purchase of Investments0.000.000.000.000.000.00-0.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00-0.000.00
Other Uses0.090.00-1.71-0.57-8.690.00--4.19-1.19
Other Sources8.540.180.000.000.001.47-0.000.00
Cash from Investing Activities-193.45-214.23-220.46-137.9846.58-136.26--983.27-85.19
Cash Dividends Paid0.000.000.000.00-174.81-62.13-0.000.00
Change in Capital Stock-24.010.00199.120.000.000.00-143.940.00
Repurchase of Common Pref Stock-24.010.000.000.000.000.00-0.000.00
Sale of Common Pref Stock0.000.00199.120.000.000.00-143.940.00
Proceedsfrom Stock Options0.000.00199.120.000.000.00-143.940.00
Issuance or Reduction of Debt, Net-14.26-7.99-107.22-7.03-16.41-138.28-699.99-5.67
Change in Long Term Debt-14.26-7.99-107.22-7.03-16.41-138.28-671.99-5.67
Issuance of Long Term Debt0.000.001.15131.62202.931,141.75-681.470.00
Reduction of Long Term Debt-14.26-7.99-108.37-138.65-219.34-1,280.02--9.49-5.67
Net Financing Active Other Cash Flow-93.36-92.90-67.26-95.24-79.11-83.50--0.771.79
Other Financing Activities Uses-116.85-108.51-83.30-119.98-83.45-86.86--9.44-7.76
Cash from Financing Activities-131.63-100.8924.64-102.26-270.33-283.91-843.15-3.88
Net Change in Cash156.80152.82119.21-18.55-262.11-273.26--20.65-4.95
Free Cash Flow282.30256.03127.5284.29-189.477.91--2.063.62
Preferred Dividends (Cash Flow)-0.000.000.000.000.00-0.000.00
Price to Free Cash Flow5.194.8819.12------
Deferred Taxes & Investment Tax Credit-43.5924.044.0046.12-30.65-49.70-12.71

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments766.24724.48609.69709.60609.44540.63
Short Term Receivables691.64719.15709.19761.70760.31821.64
Inventories110.10116.02119.84118.59121.59118.40
Other Current Assets602.47495.23581.43468.93466.11396.44
Total Current Assets2,170.452,054.882,020.142,058.821,957.461,877.11
Net Property, Plant & Equipment2,113.622,128.792,142.162,144.022,099.312,067.26
Total Investments and Advances19.1818.800.000.000.000.00
Intangible Assets948.88966.94967.60968.79967.60954.61
Deferred Tax Assets3.205.826.656.8918.4117.07
Other Assets97.68104.86116.2749.79111.59111.19
Total Assets5,353.025,280.085,252.825,290.215,154.375,027.25
Short Term Debt Incl. Current Port. of LT Debt28.7628.5737.6376.9419.3419.33
Accounts Payable399.04429.77419.72457.94381.85364.45
Income Tax Payable---15.01--
Other Current Liabilities589.56517.98494.13496.66541.96497.09
Total Current Liabilities1,017.36976.32951.481,046.54943.15880.87
Long Term Debt2,236.382,237.762,248.092,241.012,256.252,247.35
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities317.60324.60322.04317.69323.12252.66
Total Liabilities3,571.343,538.673,521.613,605.243,522.533,380.88
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1,396.181,350.551,336.831,287.901,238.211,254.59
Total Shareholders Equity1,396.181,350.551,336.831,287.901,238.211,254.59
Accumulated Minority Interest385.50390.86394.39397.07393.63391.79
Total Equity1,781.681,741.401,731.221,684.961,631.851,646.38
Total Liabilities & Stockholders Equity5,353.025,280.085,252.825,290.215,154.375,027.25
Book Value Per Share9.919.529.349.018.658.77
Tangible Book Value Per Share3.172.702.582.231.892.10
Full-Time Employees---25,200--
Price to Book Ratio1.811.050.951.021.511.66
Return on Assets2.781.522.642.564.125.29
Return on Equity11.106.0110.6911.2318.2825.56
Return on Invested Capital1.230.471.111.27-0.672.08
Quick Ratio2.031.992.001.851.952.00
Current Ratio2.132.102.121.972.082.13

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income63.3934.6958.4974.261.2195.70
Depreciation41.0641.3442.9941.0439.1639.31
Other Funds (Non Cash)3.959.67-1.1410.2910.7611.32
Funds from Operations115.5389.2099.91154.3068.73145.53
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital6.40107.53-160.1369.1483.06-28.04
Cash from Operating Activities121.93196.74-60.22223.44151.80117.49
Capital Expenditures-48.81-38.68-28.09-84.00-58.80-46.20
Net Assets From Acquisitions0.000.000.00-2.500.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.32-0.320.000.090.17-0.05
Other Sources8.36-0.190.190.180.000.00
Cash from Investing Activities-40.14-39.18-27.90-86.23-58.63-46.25
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-10.98-13.030.000.000.000.00
Repurchase of Common Pref Stock-10.98-13.030.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-3.84-3.29-3.64-3.48-1.61-1.51
Change in Long Term Debt-3.84-3.29-3.64-3.48-1.61-1.51
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-3.84-3.29-3.64-3.48-1.61-1.51
Net Financing Active Other Cash Flow-25.21-26.45-8.14-33.56-22.75-24.15
Other Financing Activities Uses-30.95-27.16-25.18-33.56-27.39-24.15
Cash from Financing Activities-40.03-42.77-11.79-37.05-24.36-25.66
Net Change in Cash41.76114.78-99.91100.1668.8145.59
Free Cash Flow73.12158.06-88.31139.4493.0071.29
Price to Free Cash Flow5.194.665.634.9012.0817.48

Revenue breakdown

Services-General Medical & Surgical Hospitals, NEC2024: 5.97B 2025: 6.32B
United States2024: 5.97B 2025: 6.32B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3015.69%3.4M22.0M431.22K
2026-10-1517.07%3.8M22.0M458.16K
2026-09-3021.07%4.6M22.0M456.99K
2026-09-1520.82%4.6M22.0M484.26K
2026-08-3117.74%3.9M22.0M534.20K
2026-08-1418.85%4.1M22.0M557.48K
2026-07-3119.34%4.3M22.3M560.89K
2026-07-1520.64%4.6M22.3M528.74K
2026-06-3020.11%4.5M22.3M490.41K
2026-06-1516.20%3.6M22.4M449.70K
2026-05-2913.47%3.0M22.5M395.06K
2026-05-1512.81%2.9M22.5M401.02K
2026-04-3013.82%3.1M22.5M396.20K
2026-04-1513.09%2.9M22.4M396.60K
2026-03-3112.28%2.8M23.2M404.18K
2026-03-1312.01%2.8M23.2M424.88K
2026-02-2711.47%2.7M23.2M452.76K
2026-02-1310.99%2.6M23.2M524.89K
2026-01-3012.46%2.9M23.2M563.62K
2026-01-1512.48%2.9M23.2M554.23K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.000.000.00-0.000.00---
call5.000.000.005.59-0.000.00---
call7.500.000.004.84-3.000.00---
call10.000.000.007.79-43.000.00---
call12.500.000.002.90-1630.00---
call15.000.000.001.30-7.000.00---
call17.500.000.000.69-1.000.00---
call20.000.000.000.95-2.000.00---
put2.500.000.000.05-8.000.00---
put5.000.000.000.05-7.000.00---
put7.500.000.000.05-15.000.00---
put10.000.000.000.15-7.000.00---
put12.500.000.000.03-15.000.00---
put15.000.000.000.05-45.000.00---
put17.500.000.001.00-13.000.00---
put20.000.000.0010.93-0.000.00---

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-10-238-KCurrent report2026-10-19SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-294Statement of changes in beneficial ownership of securities2026-09-25SEC
2026-09-048-KCurrent report2026-09-04SEC
2026-08-27144Filing for proposed sale of securities under Rule 144.SEC
2026-08-25144Filing for proposed sale of securities under Rule 144.SEC
2026-08-20144Filing for proposed sale of securities under Rule 144.SEC
2026-08-18144Filing for proposed sale of securities under Rule 144.SEC
2026-08-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-07-01SEC
2026-06-308-KCurrent report2026-06-26SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-084Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-06-028-KCurrent report2026-06-02SEC
2026-05-268-KCurrent report2026-05-20SEC
2026-05-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-058-KCurrent report2026-05-05SEC
2026-04-08ARSAnnual report to security holders. 2025-12-31SEC
2026-04-08DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-08DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-05-20SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-04-01SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-04-01SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-04-01SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-04-01SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-04-01SEC
2026-04-024Statement of changes in beneficial ownership of securities2026-04-01SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-06186.40K200
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
CHAI TRUST CO LLC53.89%
Ventas, Inc.6.52%
BlackRock, Inc.1.52%
AMERIPRISE FINANCIAL INC1.47%
GOLDENTREE ASSET MANAGEMENT LP1.10%
AQR CAPITAL MANAGEMENT LLC1.01%
CastleKnight Management LP0.75%
VANGUARD CAPITAL MANAGEMENT LLC0.67%
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.59%
GEODE CAPITAL MANAGEMENT, LLC0.44%

Funds

Fund% owned
Floating Rate Income Fund1.85%
Touchstone Funds Group Trust-Touchstone High Yield Fund0.86%
Columbia Small Cap Value Discovery Fund0.72%
High Income Fund0.52%
VANGUARD TOTAL STOCK MARKET INDEX FUND0.46%
iShares Russell 2000 ETF0.45%
EA Bridgeway Omni Small-Cap Value ETF0.38%
Avantis U.S. Small Cap Value ETF0.37%
AVIP High Income Bond Portfolio0.37%
Columbia Small Cap Value and Inflection Fund0.32%

OakChart. ARDT. Cached 15 minutes.